TL;DR Below is an open-source common-line tool for converting an OHDSI OMOP cohort (defined in ATLAS) to a FHIR bundle and vice versa.
OHDSI OMOP CDM is one of the most popular clinical data models for health data warehouses. The simple, but clinically motivated data structure is intuitively appealing to clinicians leading to its good adoption. In this respect, it has overtaken HL7-V3 which is more robust but has a steeper learning curve, especially for clinicians. The OHDSI OMOP CDM is widely used in the pharmaceutical industry for drug monitoring.
FHIR is emerging as the defacto standard for health system interoperability, owing largely to its simplicity and the use of existing and popular standards such as REST. As NoSQL databases become more and popular in healthcare, FHIR can also be a good persistence schema. It aligns well with search technologies such as elasticsearch.
As both standards are popular, conversion from one to the other may be commonly required. Researchers at Georgia Tech have an open-source tool – GT-FHIR2 – for mapping an existing OHDSI OMOP CDM database as FHIR endpoint. However, conversion between existing systems may not be easy with a full-stack solution.
I have a simpler solution that I believe will be useful in the following scenarios:
- To export a cohort to a FHIR based analytics tool.
- To load new resources to OMOP CDM databases for incremental ETL.
Omopfhirmap is a command-line tool for mapping a OHDSI cohort, defined in ATLAS, to a FHIR bundle that can be optionally submitted to a FHIR server for processing. Conversely, it can process a FHIR bundle and add resources to an existing CDM database ignoring duplicates. Unlike GT-FHIR2, the OMOP on FHIR Project at Georgia Tech omopfhirmap does not expose OMOP database as FHIR endpoints.
I have used spring-boot and JPA for easy wiring of services and abstraction of database and the hapi-fhir as it is an obvious choice for any java based FHIR applications. It is still a work in progress and any help will be appreciated (Refer to CONTRBUTING.md).